Study Results: Subsequent Chemotherapy May Increase Risk of Joint Infection for Patients with Joint Replacements

Researchers at Sinai Hospital of Baltimore have found a possible relationship between receiving chemotherapy within a year of total joint replacement surgery and increased incidence of infection in the replaced joint. Findings published this month in the Archives of Orthopaedic and Trauma Surgery.

Orthopaedic Surgeon Speaks to the Importance of Preparing Your Home for Joint Replacement Surgery

ROSEMONT, Ill. (January 30, 2023)—With almost 1.25 million hip and knee replacement surgeries performed in the United States[i], joint replacement surgery is one of the most common orthopaedic procedures performed today. The recovery period following an orthopaedic surgery usually involves…

Mount Sinai Study Finds That Blood Clotting Drug Commonly Used for Orthopedic Surgeries Does Not Increase Complications for High-Risk Patients

Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients

The Future of Joint Replacement is Now

At Rush, orthopedic surgeons Vasili Karas, MD, MS, and Denis Nam, MD, are using new technology to perform joint replacement surgery. Karas and Nam have been using and studying three different types of robotic-assisted surgery in both knee replacement and hip replacement.

Clinical Utility of Hana® Orthopedic Table Highlighted in New Study: 97% of Direct Anterior Approach Hip Replacement Patients Needed Little to No Opioid Pain Medication After Surgery

Mizuho OSI®, a leading manufacturer of specialty surgical tables and pressure injury abatement solutions would like to announce the publication of a new clinical study titled “23-hour Total Hip Replacement Requiring Only 3.5 Opioid Pills Through 6 Weeks: A Non-selected Prospective Consecutive One Year Cohort”, by Andrew Wickline MD, now appearing in the peer-reviewed Journal of Orthopedic Experience & Innovation (JournalOEI)

Rick Sumner Named Fellow of the American Association for the Advancement of Science

Rick Sumner, PhD, has spent years studying implants and ways to decrease failure by catching it early.
In recognition of his distinguished contributions to understanding bone remodeling around orthopedic implants and developing strategies to improve implant fixation, Sumner has been named a fellow of the American Association for the Advancement of Science (AAAS).